Treatment of Acute Venous Thromboembolism

Sashi Nair; Nina Garza; Matt George; Scott Kaatz

doi:10.1016/j.mcna.2020.03.004

Treatment of Acute Venous Thromboembolism

Sashi Nair, Nina Garza, Matt George, Scott Kaatz

Research output: Contribution to journal › Review article › peer-review

Abstract

“Acute venous thromboembolism is a common disease seen by nearly all hospitalists. The advent of low molecular weight heparin (LMWH) several decades ago ushered in the era of early hospital discharge and home treatment. More recently, the direct oral anticoagulants (DOACs) have further simplified outpatient treatment and some offer treatment without parenteral therapy. Use of DOACs for cancer-associated venous thromboembolism is emerging and is a welcome evolution of care to spare oncologic patients the burden of daily LMWH injections.”

Original language	English (US)
Pages (from-to)	631-646
Number of pages	16
Journal	Medical Clinics of North America
Volume	104
Issue number	4
DOIs	https://doi.org/10.1016/j.mcna.2020.03.004
State	Published - Jul 2020
Externally published	Yes

Bibliographical note

Publisher Copyright:
© 2020 Elsevier Inc.

Keywords

Anticoagulation
Deep vein thrombosis
Pulmonary embolism
Risk stratification
Thrombolytic

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1016/j.mcna.2020.03.004

Find It

Find It at U of M Libraries

Cite this

@article{f0f60e8dec9347d9a60c8a60c05fd06c,

title = "Treatment of Acute Venous Thromboembolism",

abstract = "“Acute venous thromboembolism is a common disease seen by nearly all hospitalists. The advent of low molecular weight heparin (LMWH) several decades ago ushered in the era of early hospital discharge and home treatment. More recently, the direct oral anticoagulants (DOACs) have further simplified outpatient treatment and some offer treatment without parenteral therapy. Use of DOACs for cancer-associated venous thromboembolism is emerging and is a welcome evolution of care to spare oncologic patients the burden of daily LMWH injections.”",

keywords = "Anticoagulation, Deep vein thrombosis, Pulmonary embolism, Risk stratification, Thrombolytic",

author = "Sashi Nair and Nina Garza and Matt George and Scott Kaatz",

note = "Publisher Copyright: {\textcopyright} 2020 Elsevier Inc.",

year = "2020",

month = jul,

doi = "10.1016/j.mcna.2020.03.004",

language = "English (US)",

volume = "104",

pages = "631--646",

journal = "Medical Clinics of North America",

issn = "0025-7125",

publisher = "W.B. Saunders Ltd",

number = "4",

}

TY - JOUR

T1 - Treatment of Acute Venous Thromboembolism

AU - Nair, Sashi

AU - Garza, Nina

AU - George, Matt

AU - Kaatz, Scott

PY - 2020/7

Y1 - 2020/7

N2 - “Acute venous thromboembolism is a common disease seen by nearly all hospitalists. The advent of low molecular weight heparin (LMWH) several decades ago ushered in the era of early hospital discharge and home treatment. More recently, the direct oral anticoagulants (DOACs) have further simplified outpatient treatment and some offer treatment without parenteral therapy. Use of DOACs for cancer-associated venous thromboembolism is emerging and is a welcome evolution of care to spare oncologic patients the burden of daily LMWH injections.”

AB - “Acute venous thromboembolism is a common disease seen by nearly all hospitalists. The advent of low molecular weight heparin (LMWH) several decades ago ushered in the era of early hospital discharge and home treatment. More recently, the direct oral anticoagulants (DOACs) have further simplified outpatient treatment and some offer treatment without parenteral therapy. Use of DOACs for cancer-associated venous thromboembolism is emerging and is a welcome evolution of care to spare oncologic patients the burden of daily LMWH injections.”

KW - Anticoagulation

KW - Deep vein thrombosis

KW - Pulmonary embolism

KW - Risk stratification

KW - Thrombolytic

UR - http://www.scopus.com/inward/record.url?scp=85085766254&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85085766254&partnerID=8YFLogxK

U2 - 10.1016/j.mcna.2020.03.004

DO - 10.1016/j.mcna.2020.03.004

M3 - Review article

C2 - 32505257

AN - SCOPUS:85085766254

SN - 0025-7125

VL - 104

SP - 631

EP - 646

JO - Medical Clinics of North America

JF - Medical Clinics of North America

IS - 4

ER -

Treatment of Acute Venous Thromboembolism

Abstract

Bibliographical note

Keywords

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this